Price
Target price
€30.00
€30.00
-1.360%
-0.4
-1.360%
€50.54
04.06.25 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Agios Pharmaceuticals Inc. Stock
A loss of -1.360% shows a downward development for Agios Pharmaceuticals Inc..
We see a rather positive sentiment for Agios Pharmaceuticals Inc. with 9 Buy predictions and 2 Sell predictions.
With a target price of 50 € there is a hugely positive potential of 66.67% for Agios Pharmaceuticals Inc. compared to the current price of 30.0 €.
So far the community has only identified positive things for Agios Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | -1.360% | 5.634% | 12.782% | -31.818% | -5.660% | 63.043% | -31.444% |
| Ironwood Pharmaceuticals | -7.170% | -10.545% | -38.500% | -91.517% | -88.286% | -95.256% | -94.472% |
| Arrowhead Pharmaceuticals Inc. | 3.230% | 4.206% | 28.285% | -35.037% | -20.303% | -54.555% | -51.135% |
| Novocure Ltd | -1.370% | -14.583% | 0.174% | -29.371% | -50.618% | -80.703% | -76.153% |
Comments
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $58.00 price target on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for AGIO provided by MarketBeat
